Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513206

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+487,540
SEC-reported price per share
$4.73
Number of holders
32
Value change
-$2,698,914
Number of buys
12
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,606,000

Security key

046513206

Report period

Q1 2026

Institutions

32

Top holders

10

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Adiumentum Capital Fund I LP
Disclosed value leader
Adiumentum Capital Fund I LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 20% 13D/G row: Adiumentum Capital Fund I LP Showing 1-6 of 15 holder rows.

Quick read

Adiumentum Capital Fund I LP leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Adiumentum Capital Fund I LP's linked filing trail.
Comparable ownership Top 5
Adiumentum Capital Fund I LP 20%
Panacea Innovation Ltd 20%
EcoR1 Capital, LLC 9.9%
Adage Capital Management, L.P. 8.6%
Pascal Touchon 0.81%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Adiumentum Capital Fund I LP
3/4/5 13D/G
Director, Other*, 10%+ Owner
20%
from 13D/G
$10,487,308
1,586,588 shares
mixed-class rows
16 May 2025
Panacea Innovation Ltd
13D/G
Panacea Innovation Limited
20%
1,632,345 shares
-$1,154,619 12 Jan 2026
EcoR1 Capital, LLC
13F 13D/G
Company
9.9%
from 13D/G
$10,368,880
573,183 shares
31 Dec 2025
Adage Capital Management, L.P.
13D/G
8.6%
700,000 shares
$0 31 Mar 2026
Pascal Touchon
3/4/5
Director
0.81%
$589,339
77,955 shares
10 Jun 2025
Carol Giltner Gallagher
3/4/5
Director
0.34%
$249,570
33,012 shares
10 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
32
Shares
2,564,230
Rows available
32
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
32
Q1 2026 holders
32
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .